Delivery Order SPE2DX15D8003-SPE2DX24F7D7D
Award Date
5/8/24
Potential Completion Date
5/9/24
Potential Value
$4.4K
Federal Agency
Medical Supply Chain
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The fixed-price contract has a ceiling value of $6,350.45 and a period of performance through March 10, 2025. Dakota Drug, Inc. is an established federal contractor, holding a large Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 to provide a wide range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product Mounjaro (12.5 mg/0.5 ml pen, 0.5 ml). The contract, valued at $1,844.88, has a performance period ending on May 16, 2024. This contract award is not associated with a larger vehicle and does not have a set-aside designation. As a prime contractor, Dakota Drug,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed-price, with a ceiling value of $2,468.66, and an ultimate completion date of November 5, 2024. This contract is not associated with a set-aside program. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract is part...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,041.10, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period through January 2, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,589.88, is for the delivery of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop Support Medical's ECAT...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,511.38, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of March 14, 2025. Dakota Drug, Inc. is also the holder of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84 and a period of performance through January 24, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,731.97 contract is for the provision of Mounjaro 15 mg/0.5 ml pen 0.5 ml, a prescription medication. This delivery order contract has an ultimate completion date of April 23, 2024 and was awarded on April 22, 2024. The...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Mounjaro 7.5 mg/0.5 ml pens. The contract has a ceiling value of $1,958.20 and a period of performance through October 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA Troop Support Medical division, valued at $999,999,999.00, to provide a...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award, valued at $2,006.80, was made to Dakota Drug, Inc., a self-certified small disadvantaged business, on February 21, 2025, with a completion date of February 24, 2025. The contract is a Firm Fixed Price Delivery Order, and is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical...